FDA Inspection 1179250 — Biomat USA Inc
The FDA completed an inspection of Biomat USA Inc on Aug 29, 2022 in Dayton, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 29, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Dayton, OH (United States)